FDA Advisory Committee Recommends Approval of SPRAVATO(TM) (esketamine) Nasal Spray CIII for Adults - PharmiWeb.com

Submitted by Anonymous (not verified) on Tue, 02/12/2019 - 21:57

FDA Advisory Committee Recommends Approval of SPRAVATO(TM) (esketamine) Nasal Spray CIII for Adults  PharmiWeb.comTITUSVILLE, N.J., Feb. 12, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and ...